EP1633390 - Bibliographic data

STABILIZED PHARMACEUTICAL GLP-1 PEPTIDE COMPOSITIONS

Last update	31/05/2025
Legal status	Brevet déchu
Origin	Euro-PCT

(73) Holder	NOVO NORDISK A/S Novo Allé 2880 Bagsværd Danemark
(72) Inventors	JUUL-MORTENSEN, Claus Ernst Meyers Gade 12 Dk-1772 Kobenhavn V Danemark ENGELUND, Dorte, Kot Gassehaven 39 DK-2840 Holte Danemark
(74) Agent	Mail recipient NIELSEN, LARS BALZER ET AL Novo Nordisk A/S Corporate Patents Novo Allée 2880 Bagsvaerd Danemark

(21) Request number	EP04735870.0
(22) Request date	03/06/2004

(11) Publication number	EP1633390
Publication date	18/01/2012

(54) Title of the invention	STABILIZED PHARMACEUTICAL GLP-1 PEPTIDE COMPOSITIONS
(51) International classification	A61K 38/26
International classification (before reform)	None

Claimed priority	(31) Number: 200300819 (32) Date: 03/06/2003 (33) Country: DK (31) Number: 476279 P (32) Date: 05/06/2003 (33) Country: US (31) Number: 200400075 (32) Date: 19/01/2004 (33) Country: DK (31) Number: 538525 P (32) Date: 22/01/2004 (33) Country: US
Initial application	None
Divisional application	None

Expected annuity	Annuity: 9 - Amount: 120 € - Due date 02/07/2012 Surtax: 9 - Amount: 24 € - Due date 03/01/2013
Last annuity	None

Publication	BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2012/1, of 31/03/2012
History	Publication de la délivrance du brevet européen - Legal date 18/01/2012 Déchéance du brevet d'invention après période de grâce - Legal date 30/06/2012 Entrée en période de grâce du brevet d'invention - Legal date 02/07/2012